Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients
Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment